These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6417576)

  • 21. Convulsant effect of Ro 5-4864, a peripheral type benzodiazepine, on the baboon (Papio papio).
    Valin A; Bryere P; Naquet R
    Neurosci Lett; 1986 May; 66(2):210-4. PubMed ID: 3014388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats.
    Little HJ; Taylor SC; Nutt DJ; Cowen PJ
    Eur J Pharmacol; 1985 Jan; 107(3):375-7. PubMed ID: 3920059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of benzodiazepines on thymus cell proliferation.
    Stepien H; Pawlikowska A; Pawlikowski M
    Thymus; 1988-1989; 12(2):117-21. PubMed ID: 3150629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines.
    Cumin R; Bonetti EP; Scherschlicht R; Haefely WE
    Experientia; 1982 Jul; 38(7):833-4. PubMed ID: 6809488
    [No Abstract]   [Full Text] [Related]  

  • 25. Benzodiazepine antagonist Ro 15-1788 counteracts the prolactin-lowering effects of other benzodiazepines in rats.
    Lotz W
    Neuroendocrinology; 1982; 35(1):32-6. PubMed ID: 6287328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in benzodiazepine receptors by acute stress: different effect of chronic diazepam or RO 15-1788 treatment.
    Medina JH; Novas ML; De Robertis E
    Eur J Pharmacol; 1983 Dec; 96(3-4):181-5. PubMed ID: 6327328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory regulation of amylase release in rat parotid acinar cells by benzodiazepine receptors.
    Okubo M; Kawaguchi M
    Eur J Pharmacol; 1998 Oct; 359(2-3):243-9. PubMed ID: 9832396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural actions of Ro 5-4864: a peripheral-type benzodiazepine?
    Pellow S; File SE
    Life Sci; 1984 Jul; 35(3):229-40. PubMed ID: 6087055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissimilarities between benzodiazepine-binding sites and adenosine uptake sites in astrocytes and neurons in primary cultures.
    Bender AS; Hertz L
    J Neurosci Res; 1987; 17(2):154-61. PubMed ID: 3035203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of the muscle relaxant effect of diazepam but not of progabide by a specific benzodiazepine antagonist: Ro 15-1788.
    Schwarz M; Turski L; Sontag KH
    Eur J Pharmacol; 1983 May; 90(1):139-42. PubMed ID: 6409655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective antagonists of benzodiazepines.
    Hunkeler W; Möhler H; Pieri L; Polc P; Bonetti EP; Cumin R; Schaffner R; Haefely W
    Nature; 1981 Apr; 290(5806):514-6. PubMed ID: 6261143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appetite-modulating drugs in dwarf goats, with special emphasis on benzodiazepine-induced hyperphagia and its antagonism by flumazenil and RO 15-3505.
    Van Miert AS; Koot M; Van Duin CT
    J Vet Pharmacol Ther; 1989 Jun; 12(2):147-56. PubMed ID: 2501511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
    Paronis CA; Bergman J
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
    O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
    Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects and benzodiazepine antagonist activity of Ro 15-1788 (flumazepil) in pigeons.
    Witkin JM; Barrett JE
    Life Sci; 1985 Oct; 37(17):1587-95. PubMed ID: 2932617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hypothermic effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788, in mice.
    Sugaya K; Matsuda I; Kubota K
    Jpn J Pharmacol; 1985 Oct; 39(2):277-80. PubMed ID: 2868143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of adenosine in the central actions of the benzodiazepines.
    Phillis JW; O'Regan MH
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):389-404. PubMed ID: 2900536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663.
    Green AR; Nutt DJ; Cowen PJ
    Psychopharmacology (Berl); 1982; 78(3):293-5. PubMed ID: 6296905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice.
    Burkard WP; Bonetti EP; Haefely W
    Eur J Pharmacol; 1985 Feb; 109(2):241-7. PubMed ID: 2986997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.